PPC
MRK icon

Park Place Capital’s Merck MRK Stock Holding History

Park Place Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831K Sell
6,461
-474
-7% -$55.5K 0.13% 103
2026
Q1 		$834K Sell
6,935
-7,279
-51% -$840K 0.17% 86
2025
Q4 		$1.5M Sell
14,214
-615
-4% -$57.7K 0.31% 53
2025
Q3 		$1.24M Buy
14,829
+1,514
+11% +$125K 0.26% 64
2025
Q2 		$1.09M Buy
13,315
+10,386
+355% +$826K 0.25% 74
2025
Q1 		$263K Sell
2,929
-2,234
-43% -$209K 0.07% 161
2024
Q4 		$514K Sell
5,163
-2,339
-31% -$241K 0.14% 119
2024
Q3 		$852K Buy
7,502
+488
+7% +$58K 0.24% 94
2024
Q2 		$868K Sell
7,014
-2,679
-28% -$345K 0.28% 78
2024
Q1 		$1.28M Sell
9,693
-3,101
-24% -$382K 0.46% 56
2023
Q4 		$1.39M Sell
12,794
-1,100
-8% -$114K 0.56% 50
2023
Q3 		$1.43M Buy
13,894
+728
+6% +$78.5K 0.42% 52
2023
Q2 		$1.52M Sell
13,166
-441
-3% -$50.1K 0.43% 47
2023
Q1 		$1.45M Sell
13,607
-4,433
-25% -$479K 0.41% 53
2022
Q4 		$2M Buy
+18,040
New +$1.84M 0.56% 35

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Park Place Capital's MRK Position: Q2 2026 in Review

Park Place Capital reduced its Merck (MRK) stake by 6.8% in Q2 2026, selling an estimated $55.5K and leaving 6,461 shares worth $831K. The position accounts for 0.13% of the portfolio, ranked #103.

Park Place Capital first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $2M in Q4 2022. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Park Place Capital held 6,461 shares of Merck worth $831K as of Q2 2026.
  • Park Place Capital sold 474 Merck shares in Q2 2026, an estimated $55.5K.
  • Merck made up 0.13% of Park Place Capital's portfolio in Q2 2026, its #103 holding.
  • Park Place Capital first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's Merck position peaked at $2M in Q4 2022.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.